维普期刊资源整合服务平台（V6.5）

88篇 您的检索式：作者名="CLOZEL M"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Mechanisms of ET-l-induced endothelial dysfunction显示文摘	Iglarz M Clozel M	2007	J Cardiovasc Pharmacol2007，50，6：	1
2	Role of endothelin in fibrosis and anti-fibrotic potential of bosentan显示文摘	Clozel M Salloukh H	2005	Ann Med2005，37，1：	1
3	Down regu lation of endothe lin receptors by autocrine production of endothelin-l显示文摘	Clozel M Loffler BM Breu V	1993	AM J Physiol1993，265，1：	1
4	Pharmacokinetics and pharmacodynamics of tezosentan,an intravenous dual endothelin receptor antagonist,following chronic infusion in healthy subjects显示文摘	Dingemanse J Clozel M van Giersbergen PL	2002	Br J Clin Pharmacol2002，53，4：	1
5	The urotemin-Ⅱ receptor antagonist palosuran improves pancreatic and renal function in diabetic rats显示文摘	Clozel M Hess P Qiu C	2006	J Pharmacol Exp Ther2006，316，3：	1
6	Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure显示文摘	Clozel M Fischli W	1993	JAM Coll Cardiac1993，22，：	1
7	Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction显示文摘	Clozel M Qiu CB Qiu CS	2002	J Am Col Cardiol2002，39，1：	1
8	Calcium blockade versus ACE inhibition in clipped and unclipped kidneys Of 2K- 1Crats显示文摘	Veniant M Heudes D Clozel JP	1994	Kidney Int1994，46，2：	1
9	The urotensinⅡreceptor antagonist palosuran improves pancreatic and renal function in diabetic rats显示文摘	Clozel M Hess P Qiu C	2006	Pharmacol Exp Ther2006，316，3：	1
10	The cardiovascular physiology and pharmacology of endothelin - 1 显示文摘	Thorin E Clozel M	2010	Adv Pharmacol2010，60，：	1
11	Pathophysiological role of revealed by the first orally active endothelin receptor antagonist显示文摘	Clozel M Breu V Burri K	1993	Nature1993，365，：	1
12	Entry-into-humans study with tezosentan, an intravenous dual endothelin receptor antagonist显示文摘	Dingemanse J Clozel M Van Giersbergen PL	2002	J Cardiovasc Pharmaco12002，39，6：	1
13	Downregulation of endothelin receptors by autocrine production of endothelin-1 显示文摘	Clozel M Loftier BM Breu V	1993	Am J Physiol1993，265，1：	1
14	Mechanisms of ET-l-induced endothelial dysfunction显示文摘	Iglarz M Clozel M	2007	J Cardiovasc Pharmacol2007，50，6：	1
15	The effect of Dosentan, a new potent endothelin receptor antagonist,on the pathogenesis of cerebral vasospasm显示文摘	Clozel M Sakai S	1995	Neurosurgery1995，37，1：	1
16	Short -term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction显示文摘	Clozel M Qiu CS	2002	J Am Coll Cardiol2002，39，1：	1
17	The role of ETB receptors in norrnotensive andhypertensive rats as revealed by the non-peptide selective ETB receptor antagonist Ro 46-8443 显示文摘	CLOZEL M BREU V	1996	FEBS Lett1996，383，12：	1
18	Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction显示文摘	Clozel M Qiu C Qin CS	2002	J Am Coll Cardiol2002，39，1：	1
19	The urotensin-Ⅱ receptor antagonist palosuran improves pancreatic and renal function in diabetic rats显示文摘	Clozel M Hess P Qiu C	2006	J Pharmacol Exp Ther2006，316，3：	1
20	Short-term endothelin receptor blockade with tezosentan has both immediate and long term beneficial effects in rats with myocardial infarction显示文摘	Clozel M Qiu C Qiu CS	2002	J Am Coil Cardiol2002，239，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示